Piramal Pharma Q2 FY27 Slides: 28% revenue growth, margins expand 350bps.
Piramal Pharma Q2 FY27 Slides: 28% revenue growth, margins expand 350bps.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in